DGAP-News: Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences
(firmenpresse) - Raptor Pharmaceutical Corp.
07.08.2012 12:30
---------------------------------------------------------------------------
NOVATO, Calif., 2012-08-07 12:30 CEST (GLOBE NEWSWIRE) --
Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') (Nasdaq:RPTP), today
announced that Ted Daley, President of Raptor, will present an overview of the
Company at two investor conferences in August.
The conference presentation schedule is as follows:
Canaccord Genuity Annual Growth Conference
August 14, 2012 at 10:00am ET
InterContinental, Boston, MA
Wedbush PACGROW LIFE SCIENCES Management Access Conference
August 15, 2012 at 1:55pm ET
Le Parker Meridien, New York, NY
A live audio webcast and 14-day archive of the Canaccord and Wedbush
presentations will be available at http://ir.raptorpharma.com/events.cfm
About Raptor Pharmaceutical Corp.
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ('Raptor') seeks to research,
produce, and deliver medicines that improve life for patients with severe, rare
disorders. Raptor currently has product candidates in clinical development to
potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis
('NASH'), Huntington's Disease ('HD'), aldehyde dehydrogenase deficiency
('ALDH2'), and thrombotic disorder.
Raptor's preclinical programs are based upon bioengineered novel drug
candidates and drug-targeting platforms derived from the human
receptor-associated protein and related proteins that are designed to target
cancer and infectious diseases.
For additional information, please visit www.raptorpharma.com.
The Raptor Pharmaceutical Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7180
CONTACT: Trout Group (investors)
Lauren Glaser
(646) 378-2972
lglaser(at)troutgroup.com
EVC Group (media)
Janine McCargo
(646) 688-0425
jmccargo(at)evcgroup.com
News Source: NASDAQ OMX
07.08.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Raptor Pharmaceutical Corp.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US75382F1066
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.08.2012 - 12:30 Uhr
Sprache: Deutsch
News-ID 172063
Anzahl Zeichen: 3559
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Raptor Pharmaceutical Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
